Table 5.
Lipid group | Cardiovascular events, n /Individuals, n | HR (95% CI) | P -value | |||||
---|---|---|---|---|---|---|---|---|
LDL-C | HDL-C | RC | Male | Female | Male | Female | Male | Female |
<130 | ≥ cutpoint | < cutpoint | 73/3647 | 30/3,678 | REF | |||
≥ cutpoint | 36/761 | 10/764 | 2.34 (1.29, 4.24)** | 1.20 (0.59, 2.42) | 0.005 | 0.618 | ||
≥ 130 | < cutpoint | 31/1552 | 21/1,327 | 1.25 (0.68, 2.30) | 1.67 (0.97, 2.87) | 0.469 | 0.065 | |
≥ cutpoint | 25/765 | 18/800 | 1.47 (0.72, 3.02) | 1.92 (1.07, 3.44)* | 0.293 | 0.028 | ||
<130 | < cutpoint | < cutpoint | 15/795 | 8/1,325 | 0.82 (0.34, 1.95) | 0.61 (0.28, 1.31) | 0.648 | 0.202 |
≥ cutpoint | 32/1092 | 25/987 | 0.80 (0.38, 1.69) | 2.49 (1.49, 4.17)** | 0.554 | 0.001 | ||
≥ 130 | < cutpoint | 4/301 | 6/414 | 0.91 (0.28, 2.97) | 1.40 (0.59, 3.33) | 0.871 | 0.448 | |
≥ cutpoint | 27/655 | 21/787 | 2.18 (1.13, 4.21)* | 2.19 (1.24, 3.88)** | 0.020 | 0.007 |
Corresponding to LDL-C clinical cutpoint (130 mg/dL), respective RC cutpoint was 25.7/23.7 mg/dL in male/female group. Respective HDL-C cutpoint was 40/50 mg/dL in male/female group. Adjusted for age + race + antihypertensive medications + lipid-lowering medications use + systolic blood pressure + coronary heart disease + stroke + smoking. *P < 0.05, **P < 0.01.